BOC Sciences is an industry-leading technology company committed to providing high-quality, efficient hyaluronic acid (HA) nanoparticle development and preparation services to global clients. These nanoparticles have broad applications in drug delivery, targeted therapy, and other biomedical fields. We leverage advanced technologies and a professional team to assist clients throughout the entire process, from the design and synthesis to the optimization of HA nanoparticles, ensuring that every product meets high-quality standards.
HA nanoparticles represent nanoparticle systems constructed from HA that demonstrate outstanding biodegradability alongside biocompatibility. Hyaluronic acid serves as a natural glycosaminoglycan found throughout the human body with particular concentrations in synovial fluid, skin, and eyes, where it demonstrates exceptional hydration and tissue regeneration capabilities. HA forms nanoparticles that serve drug delivery and controlled release functions via physical or chemical bonding with other molecules during nanoparticle preparation. Targeted drug release becomes possible through HA's specific binding to cell surface receptors, which helps to minimize side effects. Additionally, the high hydration of HA nanoparticles makes them widely applicable in cosmetics and skin repair.
We have a professional team of experts in biomedicine, chemical engineering, and nanotechnology, providing comprehensive services.
We use high-purity sodium hyaluronate as raw material, ensuring the high quality and performance of the nanoparticles.
BOC Sciences utilizes the latest nanoparticle preparation technologies to ensure the uniformity and controllability of the particles.
We offer personalized development, modification, and preparation solutions for HA nanoparticles based on client needs.
We provide both small-scale and large-scale production to meet the diverse needs of our clients.
The HA nanoparticles we prepare have excellent biocompatibility and degradability, suitable for various biomedical applications.
HA nanoparticles can be applied in drug delivery, gene therapy, skin repair, vaccine delivery, and more.
We implement a rigorous quality control system throughout the production process to ensure the stability and safety of each batch of products.
Based on the above synthesis technologies and modified HA raw materials, BOC Sciences, through an innovative technology platform, offers various HA-based nanocarriers. These carriers have multiple functionalities that can be used to enhance therapeutic effects, extend the in vivo circulation time of drugs, and reduce drug side effects. Below are several types of HA-based nanocarriers we provide and their characteristics:
HA-based nanogels are three-dimensional network structures formed by cross-linking HA molecules, which possess high hydration and adjustable sizes.
Stable nanostructures are formed by the ionic interaction between HA and cationic molecules or polymer materials, with good biocompatibility and controllable drug release characteristics.
Nanostructures composed of HA and synthetic or natural polymers (such as PLGA, PEG, etc.), usually having stable outer membranes and internal cavities that can encapsulate water-soluble or lipophilic drugs.
Nanostructures formed by self-assembly of HA and its derivatives. HA micelles combine the hydrophilic outer layer and hydrophobic inner core structure, effectively encapsulating hydrophobic drug molecules.
Nanocapsules have a hollow inner cavity that can accommodate drug molecules, widely applied in long-acting drug delivery, vaccine development, and anti-tumor treatment.
Multifunctional carriers formed by the combination of HA and other nanomaterials (such as gold nanoparticles, silver nanoparticles, silica nanoparticles, etc.), which can improve drug loading efficiency and drug release accuracy.
HA-based nanofibers are nanometer-sized fibers prepared by electrospinning, possessing high surface area and adjustable pore structures.
HA-based nanofilms are thin membrane structures composed of HA and other polymer materials. These films degrade slowly in the body and release encapsulated drugs.
BOC Sciences offers a variety of advanced technologies for the preparation of HA nanoparticles, including solution polymerization, emulsion polymerization, ultrasonic treatment, solvent evaporation, and more. These technologies can adjust the size, morphology, surface properties, and drug-loading capacity of the nanoparticles based on the characteristics of HA. We also combine nanoparticle modification technologies to enhance the targeting ability, drug release properties, and biocompatibility of HA nanoparticles.
HA sodium is dissolved in an aqueous solution, and then crosslinking agents (such as glutaraldehyde, carbon tetrachloride, etc.) are introduced to initiate crosslinking reactions and form HA nanoparticles.
HA sodium is first dissolved in the aqueous phase, then an oil phase is added, and an emulsifier is used to form an emulsion. Free radical polymerization or crosslinking reactions are then used to stabilize the HA nanoparticles.
HA solution is treated with ultrasound to disperse into small particles. Ultrasound can break up larger molecular clusters through mechanical vibrations, quickly facilitating the interaction between HA molecules and forming uniform nanoparticles.
The solvent evaporation method is suitable for synthesizing HA nanoparticles. In this method, HA is dissolved with a solvent (such as dichloromethane), and the solution is then dropped into a nonsolvent or the solvent is evaporated to form HA nanoparticles.
The spray drying method uses hot air to spray the HA solution into mist particles, quickly evaporating the solvent to solidify the particles into nanoparticles. This method is fast and easy to scale up for production.
The self-assembly method utilizes intermolecular interactions (such as hydrogen bonding, electrostatic forces, etc.) to spontaneously form HA nanoparticles. This method does not require external chemical crosslinkers or solvents, ensuring the high biocompatibility of the nanoparticles.
The electrospinning method uses a high-voltage electric field to draw the HA solution into nanofibers, which then form HA nanoparticles. The main advantage of this method is that it can produce nanoparticles or nanofibers with a high specific surface area.
By precisely controlling fluid flow rates and mixing patterns, the microfluidic method can precisely synthesize HA nanoparticles on the micrometer or nanometer scale. This method efficiently controls particle size distribution, morphology, and surface properties.
HA, as a natural polysaccharide, has excellent biocompatibility and biodegradability, which is why it is widely applied in drug delivery, tissue engineering, and anti-tumor treatments. However, natural HA may face challenges such as poor biological stability, low drug loading capacity, and inadequate targeting in some applications. Therefore, chemical modifications of HA have become an important means to enhance its functionality and expand its range of applications. BOC Sciences offers highly customized HA derivatives through a series of HA modification technologies to meet the needs of different fields. Below are several modified HAs that we provide:
The introduction of steroid molecules improves the biocompatibility and biological activity of HA, enhancing its cellular affinity in drug delivery.
Lipid-modified HA improves nanoparticle stability and cellular uptake efficiency, widely applied in gene therapy and vaccine delivery.
By combining with polymer materials, the mechanical strength, stability, and drug loading capacity of HA nanoparticles are enhanced.
PEGylated HA effectively prevents nanoparticles from being cleared by the reticuloendothelial system (RES), significantly improving nanoparticle stability and biodistribution in the bloodstream.
Coating nanocarriers with HA can improve their biological properties and biocompatibility, enhance their antimicrobial activity, and enable controllable site-specific drug release. Additionally, HA coating can enhance the ability of nanocarriers to evade immune cell detection and uptake by the reticuloendothelial system, while significantly improving target recognition and localization. Therefore, BOC Sciences also provides advanced HA surface modification and coating services for nanoparticles. Using HA to coat nanocarriers can significantly improve the biological properties of the nanocarriers, enhance their biocompatibility and antimicrobial activity, and extend their half-life in vivo. Our sodium hyaluronate surface modification service, with its unique technical advantages, has become an essential tool in nanoparticle preparation, providing innovative solutions for precision medicine and therapy.
BOC Sciences offers a comprehensive HA nanoparticle testing platform, specifically designed for the characterization, performance analysis, and quality control of nanoparticles. Through a series of advanced testing methods and equipment, we help clients accurately evaluate key parameters such as the physicochemical properties, stability, drug loading, release performance, targeting efficiency, and biocompatibility of HA nanoparticles, providing strong support for the development and optimization of nanoparticle-based drug delivery systems. Below are the main testing items and equipment covered by our HA nanoparticle testing platform:
HA nanoparticles, due to their unique biocompatibility, good biodegradability, and high targeting ability, demonstrate extensive application potential in multiple research fields. BOC Sciences emphasizes the applications of HA nanoparticles in drug delivery, gene therapy, cancer targeted therapy, and tissue engineering. Our HA nanoparticle technology can help clients achieve efficient drug delivery, targeted localization, and prolonged drug release. We provide comprehensive technical support to help researchers achieve breakthrough progress in related fields.
Hyaluronic acid itself is not a nanoparticle, but it can be converted into nanoparticle form through nanomaterial technologies. In this form, hyaluronic acid particles typically range from 1 to 100 nanometers in size, offering enhanced biocompatibility and permeability, making them suitable for drug delivery, skincare, and other applications. HA nanoparticles, due to their unique physicochemical properties, demonstrate good effects in targeted therapy and cell repair.
Nanoparticles in cosmetics are generally subjected to strict safety assessments and comply with relevant regulatory requirements. Due to their smaller size, nanoparticles can enhance the permeability and effectiveness of active ingredients. However, the safety of nanoparticles depends on factors such as material, size, shape, and the concentration used. Most approved nanoparticles in cosmetics are considered safe, but further experiments are needed to ensure their long-term use does not trigger adverse reactions.